Publications by authors named "Galeano S"

The eighth workshop of the Worldwide Network for Blood and Marrow Transplantation (WBMT) was held in Islamabad, Pakistan, from September 22 to 23, 2022, aiming to foster hematopoietic stem cell transplant (HSCT) activity in the World Health Organization (WHO) Eastern Mediterranean Region (EMRO). Participating countries, including Pakistan, Oman, Iran, and Saudi Arabia, reported increased HSCT in the last few years, whereas others from the EMRO and beyond, including Qatar, United Arab Emirates, Nepal, and Bangladesh, started HSCT recently and have developed HSCT programs with excellent results. During educational sessions and open dialog, participating teams and international experts from the WBMT shared their experience and discussed minimum essential requirements for establishing and expanding HSCT in emerging countries, indications for HSCT training and dissemination of knowledge, stem cell donor selection and safety, quality assurance in transplant centers, and the value and importance of transplant outcome databases.

View Article and Find Full Text PDF
Article Synopsis
  • Hematopoietic cell transplantation (HCT) is crucial for treating blood-related diseases, but Latin America faces challenges in access due to limited training programs for HCT professionals.
  • A study by the Latin-American Bone Marrow Transplantation Group surveyed 127 HCT centers across 14 countries to analyze the state of training programs, revealing that only 39% of centers responded and most programs are lacking in quality and resources.
  • Major barriers identified included insufficient funding, few transplant procedures, and a lack of qualified instructors, with proposed solutions focusing on increasing student mobility, enhancing program quality, and improving funding access.
View Article and Find Full Text PDF
Article Synopsis
  • Autologous peripheral blood stem cell (PBSC) transplantation is a common treatment for conditions like multiple myeloma and lymphomas, and it usually involves freezing the stem cells before transplant.* -
  • A recent systematic review of 19 transplant centers that performed non-cryopreserved PBSC transplants showed that the procedure is feasible and safe, with high stem cell viability and low rates of complications.* -
  • The study found that stem cell viability was over 90% for multiple myeloma and over 75% for lymphomas, with quick engraftment times, and only 1% transplant-related mortality within 100 days.*
View Article and Find Full Text PDF

Centrolenidae is a Neotropical family widely distributed in Central and South America, with its species richness concentrated in the tropical Andes. Several taxonomic problems have been identified within this family, mostly related to species with broad geographic distributions. In this study, we assessed and redefined the species boundaries of the species complex, and formally described two new species from the Andes of Ecuador.

View Article and Find Full Text PDF
Article Synopsis
  • Autologous hematopoietic cell transplantation (AHCT) is an effective treatment for multiple myeloma, with real-world data collected from 61,725 patients revealing median overall survival of 90.2 months and median progression-free survival of 36.5 months.* -
  • Cumulative relapse incidence and non-relapse mortality rates at 24 months were found to be 33% and 2.5% respectively, with better outcomes linked to factors like younger age, certain disease subtypes, and high performance status.* -
  • Global variations were observed in patient outcomes based on registry data, influenced by differences in patient characteristics, use of maintenance treatments, and macroeconomic factors, highlighting the safety and effectiveness of AH
View Article and Find Full Text PDF
Article Synopsis
  • * Both types of HCT are risky and complicated, but global collaboration among medical professionals has established it as a standard treatment for many serious blood-related illnesses, resulting in improved patient outcomes.
  • * Over 1.5 million HCT procedures were performed from 1957 to 2019, and this number continues to rise globally, supported by registries and international medical societies.
View Article and Find Full Text PDF

Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the principal activities of the Worldwide Network for Blood and Marrow Transplantation, a non-governmental organization in working relations with the World Health Organization. HCT activities are recorded annually by member societies, national registries and individual centers including indication, donor type (allogeneic/autologous), donor match and stem cell source (bone marrow/peripheral blood stem cells/cord blood). In 2018, 1,768 HCT teams in 89 countries (6 World Health Organization regions) reported 93,105 (48,680 autologous and 44,425 allogeneic) HCT.

View Article and Find Full Text PDF

Background: Information on the performance of oxygenation indices (OIs) and risk scores in patients requiring invasive mechanical ventilation (IMV) is limited. We determine the performance of the OIs and risk scores in hospitalized patients with COVID-19 to predict the requirement of IMV and death at 28 days after admission.

Methods: A retrospective study of diagnostic tests in patients admitted to the emergency department, hospitalization, and intensive care unit diagnosed with COVID-19.

View Article and Find Full Text PDF

Roadkill and landscape composition affect snakes at different spatial scales, depending on the functional trait value of the species, which is reflected in the functional diversity indices at the assemblage level. This study evaluated the effect of roads and landscape composition on snakes' functional diversity at different areas of influence (250, 500, 1000, and 2000 m buffer areas). We compared roadkill snake species with those assemblages inhabiting the adjacent vegetation in the Orinoco region, Colombia.

View Article and Find Full Text PDF
Article Synopsis
  • There is limited data on fungal and parasitic infections in stem-cell transplant recipients outside of Western Europe and North America, highlighting a gap in knowledge.
  • The WBMT Review aims to provide global guidelines for prevention, diagnosis, and treatment based on expert opinions and available evidence.
  • The paper covers various endemic and regional infections, including those classified as neglected tropical diseases by the WHO, such as leishmaniasis, Chagas disease, and malaria.
View Article and Find Full Text PDF

Literature discussing endemic and regionally limited infections in recipients of haematopoietic stem-cell transplantation (HSCT) outside western Europe and North America is scarce. This Worldwide Network for Blood and Marrow Transplantation (WBMT) article is part one of two papers aiming to provide guidance to transplantation centres around the globe regarding infection prevention and treatment, and considerations for transplantation based on current evidence and expert opinion. These recommendations were initially formulated by a core writing team from the WBMT and subsequently underwent multiple revisions by infectious disease experts and HSCT experts.

View Article and Find Full Text PDF
Article Synopsis
  • * Between 2009 and 2016, global HSCT use for AML rose significantly, particularly in resource-limited regions, with an overall 54.9% increase, although access remains heavily skewed towards high-resource areas.
  • * Utilization rates vary widely by region, with younger patients (<70 years) experiencing even more disparities; AMR-N showed the highest rates of HSCT, while AFR/EMR and AMR-S lagged far behind.
View Article and Find Full Text PDF

The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important, particularly because of the growing use of haploidentical HSCT. Compared with the strict recommendations on the suitability for unrelated donors, criteria for related donors allow for more discretion and vary between centres. In 2015, the donor outcome committee of the Worldwide Network for Blood and Marrow Transplantation (WBMT) proposed consensus recommendations of suitability criteria for paediatric and adult related donors.

View Article and Find Full Text PDF

A total of 5642 hematopoietic cell transplants (HCT) in 5445 patients (2196-40% allogeneic and 3249-60% autologous) were reported by 127 teams in 14 Latin American countries that answered the 2018 LABMT/WBMT Global Transplant Activity survey. The transplant rate (defined as the number of first transplants per 10 million inhabitants per year) was 85 (51 autologous and 34 allogeneic) in 2018. The main indications for allogeneic HCT were acute leukemias (60%), while plasma cell disorders and lymphomas were the most common conditions warranting autologous HCT (50 and 36%, respectively).

View Article and Find Full Text PDF

The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities through member societies, national registries and individual centers. In 2016, 82,718 first HCT were reported by 1,662 HCT teams in 86 of the 195 World Health Organization member states representing a global increase of 6.2% in autologous HCT and 7.

View Article and Find Full Text PDF

Purpose Of Review: The aim of the article is to review recent recommendations on the management of Strongyloidiasis and Chagas disease (ChD) in the context of stem-cell or solid-organ transplantation.

Recent Findings: An update on laboratory screening, detection of acute disease or reactivation and recommended preventive or therapeutic options in the transplant recipients and donors is presented. Recent epidemiological data showing new estimates on the worldwide burden of both diseases and changes in the classical distribution around the globe should increase awareness and will impact the evaluation and management of transplant recipients and donors in endemic and nonendemic regions.

View Article and Find Full Text PDF
Article Synopsis
  • Hematopoietic cell transplants are complicated and expensive, putting a lot of pressure on healthcare systems, especially in poorer countries.
  • In 2017, over 4,500 transplants were done in 13 Latin American countries, but rates varied greatly, ranging from 345 in Uruguay to only 12 in Venezuela.
  • Higher transplant costs and procedures done in private hospitals with government funding were linked to more transplants, while lower costs and public hospitals usually meant fewer transplants.
View Article and Find Full Text PDF

SARS-CoV-2 has spread rapidly worldwide, but the full impact of the COVID-19 pandemic on the field of hematopoietic cell transplantation (HCT) remains unknown. To understand this better, an 18-item online survey was disseminated by the Worldwide Network for Blood & Marrow Transplantation with questions exploring SARS-CoV-2 testing algorithms, mobilization, and cryopreservation strategies and COVID-19 infections in allogeneic related and autologous hematopoietic progenitor cell (HPC) donors. The aim of this survey was to assess the impact of the outbreak on policies relating to HPC mobilization, collection, and processing with respect to changes in daily routine.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple myeloma (MM) is a type of cancer affecting plasma cells and leads to issues like bone damage and anemia, with limited global access to effective treatments.
  • A study analyzed data from 2006-2015 on hematopoietic cell transplantation (HCT) for MM, revealing a 107% increase in autologous HCTs worldwide, particularly in high-income regions like Northern America and Europe.
  • Despite the growth in autologous HCT utilization in wealthier areas, access remains critically low in regions like Africa and the East Mediterranean, highlighting the need for improved healthcare resources and support for MM patients in low to middle-income countries.
View Article and Find Full Text PDF

Autologous stem cell transplant (ASCT) is a widely used and safe procedure to treat mostly hematologic diseases. These patients are at risk of infectious complications, which represents a major cause of morbidity and it is the second cause of mortality. This retrospective 12-year analysis of the incidence, type, and severity of infections in 266 consecutive unselected ASCT patients at our institution provides novel information addressing this issue.

View Article and Find Full Text PDF

This dataset is the first effort to combine the audio biodiversity of a taxonomic group in a selected location, the Boyacá department in Colombia. We conducted a detailed review of the sound recordings for birds from the Boyacá department within three repositories, the environmental sound collection of the Humboldt Institute, the Macaulay Library of the Cornell Lab of Ornithology, and the xeno-canto platform of the Naturalis Biodiversity Center. We selected recordings that were identified up to species and had complete metadata information.

View Article and Find Full Text PDF

Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated multidisciplinary team to optimize its safety. In addition, institutions may have different needs regarding indications based on regional disease prevalence or may have an interest in developing specialized services. Yet, structured recommendations are not commonly available.

View Article and Find Full Text PDF

Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated multidisciplinary team to optimize safety. In addition, institutions may have different needs regarding indications based on regional disease prevalence or may have an interest in developing specialized services. Structured recommendations are not commonly available, however.

View Article and Find Full Text PDF